Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
MULTI-THRESHOLD IMAGE SEGMENTATION FOR LUNG CANCER IMAGE MINING samatha gamidi kiet NLST Aug 9, 2013 NLST-33
Addressing Knowledge Gaps in Bladder Cancer Screening yair lotan University of Texas Southwestern Medical Center NLST Aug 7, 2013 NLST-31
Addressing Knowledge Gaps in Bladder Cancer Screening yair lotan University of Texas Southwestern Medical Center PLCO Aug 7, 2013 PLCO-46
Long term lung cancer risk of non-calcified nodules Paul Pinsky NCI NLST Aug 2, 2013 NLST-30
BMI, weight change, and site-specific cancer incidence in PLCO Cari Kitahara NCI, DCEG, NEB PLCO Aug 2, 2013 PLCO-45
Assessing the Effect of Increased Medical Surveillance on Thyroid Cancer Incidence in the Prostate Lung Colorectal & Ovarian Cancer Screening Trial and the National Lung Screening Trial: A Pooled Study of Two Randomized Control Trials Thomas O'Grady University at Albany School of Public Health PLCO Aug 1, 2013 PLCO-44
Assessing the Effect of Increased Medical Surveillance on Thyroid Cancer Incidence in the Prostate Lung Colorectal & Ovarian Cancer Screening Trial and the National Lung Screening Trial: A Pooled Study Thomas O'Grady University at Albany School of Public Health NLST Aug 1, 2013 NLST-29
Estimating Patient-Specific Benefits and Harms of Low-Dose Computed Tomography Screening For Lung Cancer Kyle Schmaus Archimedes, Inc. PLCO Jul 29, 2013 PLCO-43
Smoking and Lung Cancer in PLCO and NLST Neil Caporaso GEB/DCEG/NCI NLST Jul 25, 2013 NLST-28
Smoking and Lung Cancer in PLCO and NLST Rayjean Hung Sinai Health System PLCO Jul 25, 2013 PLCO-42
Artificial Neural Network Analysis of NLST Data for determining clusters of patient factors and CT lesion features most predictive of true positives and true negatives, false positives and false negatives John Weaver HealthView Preventive Medical Center NLST Jul 25, 2013 NLST-27
Estimating Patient-Specific Benefits and Harms of Low-Dose Computed Tomography Screening For Lung Cancer Kyle Schmaus Archimedes, Inc. NLST Jul 23, 2013 NLST-26
Do repeat normal lung screens lower model estimated baseline estimates of lung cancer risk? Martin Tammemagi Brock University NLST Jul 22, 2013 NLST-25
Comparison of rates of radiological imaging in control arm of PLCO vs UK population Matthew Callister Leeds Teaching Hospitals NHS Trust PLCO Jul 9, 2013 PLCO-39
A novel class prediction algorithm for the analysis of nodules in NLST Emmanuel Zachariah UMDNJ-Robert Wood Johnson Medical School NLST Jun 25, 2013 NLST-24
The natural history and screen-detectability of lung cancer: estimates from NLST and the PLCO Kevin ten Haaf Erasmus MC NLST Jun 21, 2013 NLST-23
The natural history and screen-detectability of lung cancer: estimates from NLST and the PLCO Kevin ten Haaf Erasmus MC PLCO Jun 21, 2013 PLCO-38
Use of analgesic medications and risks of breast and endometrial cancer among women in the PLCO cohort Kayleigh Majercak University of Arkansas for Medical Sciences PLCO Jun 20, 2013 PLCO-37
NLST lung cancer distribution during screening and post-screening Rowena Yip Icahn School of Medicine at Mount Sinai NLST Jun 6, 2013 NLST-20
Mortality reductions produced by a sustained low-dose helical CT screening program for lung cancer James Hanley McGill University NLST May 24, 2013 NLST-19